Sabzevari Helen 4

What Happened

• Helen Sabzevari, President and CEO of Precigen (PGEN), had restricted stock units (RSUs) convert into common stock on May 23, 2026. The filing shows 250,000 shares acquired by conversion and an equal 250,000 shares disposed (reported at $0), consistent with shares being withheld/surrendered to satisfy tax obligations. The acquisition shows no cash price (conversion), and the disposed shares are reported at $0 (tax withholding), so no cash proceeds are involved.

Key Details

• Transaction date: May 23, 2026; Filing date: May 27, 2026 (filed within the normal Form 4 reporting window).
• Acquired: 250,000 shares via conversion of derivative (RSU) — price N/A.
• Disposed: 250,000 shares (reported at $0) — shown as derivative disposition (tax withholding).
• Net effect in this filing: the converted and withheld amounts are equal, resulting in no net new shares delivered to the insider from these line items.
• Footnotes: F1 — each RSU equals one share of Precigen common stock. F2 — the reported amount represents 50% of the RSUs granted on June 26, 2025 that vested on May 23, 2026; the remaining RSUs vest in equal quarterly installments over the next three years.
• Shares owned after transaction: not specified in the provided excerpt of the filing.

Context

• These entries reflect RSU vesting and conversion, not an open-market purchase or sale; the $0 disposal is a common way to report shares surrendered/withheld to cover taxes (a cashless/withholding settlement). Such vesting-related transactions are routine compensation events and do not necessarily indicate a change in the insider’s view of the company.